A Form 4 filed on August 21, 2026 discloses that Elliott Robinson, a director at Hinge Health, Inc. (NYSE:HNGE), reported the sale of Class A Common Stock by affiliated Bessemer Venture Partners funds on August 19, 2026.

Key Highlights

  • Reporting person: Elliott Robinson, director at Hinge Health, Inc., filing as an indirect beneficial owner through Bessemer Venture Partners.
  • Shares sold: Bessemer Venture Partners X L.P. sold 13,527 shares and Bessemer Venture Partners X Institutional L.P. sold 12,699 shares of Class A Common Stock on August 19, 2026.
  • Price: Both sales were executed at a weighted average price of $90.05 per share, in multiple transactions ranging from $90.00 to $90.44.
  • Post-transaction ownership: The filing reports 0 shares of Class A Common Stock beneficially owned following the reported transactions.
  • Disclaimer: The reporting person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any.

Bessemer Funds Dispose of Hinge Health Class A Shares at $90.05 Weighted Average

According to the filing, the two affiliated entities, Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P., collectively referred to as the "Bessemer Funds," carried out the sales on August 19, 2026. BVP X sold 13,527 shares and BVP X Institutional sold 12,699 shares, both at a weighted average price of $90.05. The filing states that the transactions occurred across multiple trades at prices ranging from $90.00 to $90.44 per share.

Elliott Robinson's connection to the securities is described in the filing as indirect and passive. The filing notes he is a partner at Bessemer Venture Partners and holds an indirect economic interest in the shares through his interest in Deer X & Co. L.P., the general partner of the Bessemer Funds, as well as through certain other indirect limited partnership interests. The filing further states that "this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities." The transaction code reported is "S," indicating an open-market sale.

The filing notes that Robinson undertakes to provide full information regarding the number of shares sold at each separate price within the stated range to the issuer, any security holder, or the SEC staff upon request. The form was signed by Augie Wilkinson as attorney-in-fact on August 21, 2026.

What Was Disclosed

The filing reports the sale of a combined 26,226 shares of Hinge Health Class A Common Stock by two Bessemer Venture Partners funds on August 19, 2026, at a weighted average price of $90.05, with director Elliott Robinson named as the indirect reporting person.